Published: Wed, February 21, 2018
World | By Paul Elliott

EnLink Midstream Partners (ENLK) Stock Rating Lowered by Zacks Investment Research

The Tortoise Capital Advisors Llc holds 8.28M shares with $138.79 million value, up from 8.14 million last quarter. Enlink Midstream Partners Lp now has $5.73 billion valuation.

Shares of Enable Midstream Partners (NYSE ENBL) traded down $0.08 on Friday, reaching $14.37. About 1.64M shares traded or 30.27% up from the average.

Zacks Investment Research lowered shares of EnLink Midstream Partners (NYSE:ENLK) from a hold rating to a sell rating in a research report report published on Tuesday morning.

At the moment 18 analysts are watching EnLink Midstream, LLC (NASDAQ:ENLC), 2 rate it "Buy", 1 "Outperform", 15 "Underperform", 0 "Sell", while 0 "Hold". Wells Fargo & Company MN now owns 26,901 shares of the pipeline company's stock worth $429,000 after buying an additional 8,850 shares during the period. Extended Stay Amer Inc Unit 99/99/9999B now has $3.77B valuation. The stock increased 0.60% or $0.23 during the last trading session, reaching $38.42. Cibc World Markets Corp sold 189,700 shares as Extended Stay Amer Inc Unit 99/99/9999B (STAY)'s stock rose 2.18%. It has underperformed by 16.70% the S&P500. Therefore 54% are positive. Tudor Pickering lowered shares of Enable Midstream Partners from a buy rating to a hold rating in a report on Friday, October 20th. The firm earned "Underweight" rating on Monday, June 20 by Barclays Capital. One analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company's stock. Goldman Sachs Group initiated coverage on EnLink Midstream Partners in a report on Friday, November 17th. Goldman Sachs maintained the stock with "Neutral" rating in Thursday, May 12 report. The stock has "Equal Weight" rating by Barclays Capital on Monday, January 11. On Thursday, November 2 the stock rating was maintained by Citigroup with "Buy". Currently, the stock has a 1 Year Price Target of $18.32. It also reduced Home Depot Inc (NYSE:HD) stake by 182,713 shares and now owns 133,766 shares. Enterprise Products Partners (NYSE:EPD) was reduced too.

Investors sentiment increased to 0.72 in Q3 2017. Its down 0.04, from 1.12 in 2017Q2. For the quarter ending Jun-18, 6 analysts have a mean sales target of 1,478.95 million whilst for the year ending Dec-18, 7 analysts have a mean target of 5,972.80 million. 999,054 shares or 44.59% less from 1.80 million shares in 2017Q2 were reported. Tiaa Cref Management Ltd Limited Liability Company has invested 0.14% in BioMarin Pharmaceutical Inc. Alphamark Advisors Lc accumulated 95 shares. British Columbia - Canada-based Pacad Investment Ltd has invested 0.2% in BioMarin Pharmaceutical Inc.

Robinson Capital Management Llc holds 0.28% of its portfolio in Western Asset Investment Grade Defined Opportunity Trust Inc. for 29,656 shares. Huntington State Bank reported 0% of its portfolio in Sears Holdings Corporation (NASDAQ:SHLD). Efg Asset Mgmt (Americas) Corp holds 0.26% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:PFG) for 6,843 shares. State Common Retirement Fund holds 0.06% in BioMarin Pharmaceutical Inc. Neuberger Berman Gp Limited Liability Com has invested 0.06% in MACOM Technology Solutions Holdings, Inc.

North Star Asset Management Inc, which manages about $1.15B and $1.01 billion US Long portfolio, upped its stake in Walt Disney Co (NYSE:DIS) by 35,293 shares to 69,784 shares, valued at $6.88 million in 2017Q3, according to the filing. The company had a trading volume of 618,465 shares, compared to its average volume of 806,555. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.54 and a quick ratio of 0.49. Jennison Limited Liability Corp stated it has 12.31 million shares or 1.17% of all its holdings. 270 were reported by Edge Wealth Mgmt Ltd. Research Mgmt Co, a Massachusetts-based fund reported 501 shares. Therefore 0 are positive. BioMarin Pharmaceutical has $175 highest and $89 lowest target. Extended Stay America had 31 analyst reports since August 3, 2015 according to SRatingsIntel. Goldman Sachs downgraded the shares of ENBL in report on Friday, September 11 to "Sell" rating. The firm has "Buy" rating by Craig Hallum given on Thursday, November 9. Jefferies maintained BioMarin Pharmaceutical Inc. (NASDAQ:AMED) has "Buy" rating given on Tuesday, September 5 by Jefferies. The stock has "Neutral" rating by Bank of America on Monday, June 27. The rating was maintained by J.P. Morgan on Tuesday, July 11 with "Buy". Credit Suisse has "Outperform" rating and $14 target. As per Tuesday, January 23, the company rating was maintained by Robert W. Baird. They issued a "neutral" rating and a $16.00 price objective on the stock. (NYSE:STAY) earned "Buy" rating by Stifel Nicolaus on Wednesday, January 25. (NASDAQ:MTSI) rating on Wednesday, February 7.

Analysts await BioMarin Pharmaceutical Inc.

Like this: